Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/14712598.2022.2012148
PubMed Identifier: 34904932
Publication URI: http://europepmc.org/abstract/MED/34904932
Type: Journal Article/Review
Volume: 22
Parent Publication: Expert opinion on biological therapy
Issue: 9
ISSN: 1471-2598